Zobrazeno 1 - 10
of 360
pro vyhledávání: '"V A, Mazurov"'
Autor:
N. V. Vorokhobina, S. N. Fogt, V. I. Mazurov, I. B. Beliaeva, R. K. Galakhova, K. A. Balandina, A. V. Kuznetsova
Publikováno v:
Медицинский вестник Юга России, Vol 15, Iss 3, Pp 48-54 (2024)
Currently, systemic glucocorticoids are taken by about 1–3% of the general population, up to 1.8% long-term. Moreover, about 50% of patients taking these drugs orally develop glucocorticoid-induced adrenal insufficiency (GIAI) after their withdrawa
Externí odkaz:
https://doaj.org/article/6b81a1511f9d479b8ee3723dfad68061
Autor:
T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaidukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. N. Linkova, A. V. Eremeeva
Publikováno v:
Современная ревматология, Vol 18, Iss 4, Pp 33-42 (2024)
This article presents the results of the 3-year use of netakimab (NTK), a monoclonal antibody against interleukin 17, in patients with psoriatic arthritis (PsA) as part of the phase III PATERA study. Objective: to evaluate the long-term efficacy and
Externí odkaz:
https://doaj.org/article/b3c87592f17d4bab870c501916a63055
Autor:
A. M. Lila, V. I. Mazurov, E. L. Nasonov, S. A. Lukyanov, T. V. Dubinina, I. Z. Gaidukova, A. A. Klimenko, S. A. Lapshina, G. V. Lukina, M. A. Korolev, R. O. Dreval, P. I. Pchelnikova, N. V. Shatalova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 134-139 (2024)
On 30 May, 2024, an expert meeting was held to update the approaches for the treatment of axial spondyloarthritis (axSpA). A new approach to the treatment of axSpA was considered, which consists of depleting autoreactive TRBV9+ T- lymphocytes by intr
Externí odkaz:
https://doaj.org/article/52801d0c44be476096c6a2e22269a5bb
Autor:
T. V. Dubinina, A. M. Lila, E. V. Kvasova, E. M. Agafonova, I. A. Andrianova, L. V. Ivanova, D. V. Yurk, N. A. Garaeva, E. Y. Akulinushkina, A. N. Vedekhina, I. B. Bashkova, S. A. Lapshina, Y. Y. Grabovetskaya, N. F. Semenova, M. I. Valkova, D. G. Krechikova, O. S. Mazhaeva, I. B. Vinogradova, O. V. Bugrova, S. M. Voloshenko, G. R. Enikeeva, E. S. Immis, L. F. Timasheva, E. E. Biserova, L. Z. Shaimukhametova, I. M. Patrikeeva, A. A. Barakat, P. A. Shesternya, N. M. Nikitina, M. I. Yupatova, O. N. Anoshenkova, M. A. Korolev, Y. B. Ubshaeva, E. A. Vasilenko, E. V. Zonova, O. B. Nesmeyanova, E. A. Bogdanova, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko
Publikováno v:
Современная ревматология, Vol 18, Iss 2, Pp 41-50 (2024)
NiSpAR is a non-interventional, multicenter study whose aim was to describe a cohort of patients with non-radiological axial spondyloarthritis (nr-axSpA) and approaches to its diagnosis in the Russian Federation.Material and methods. The study involv
Externí odkaz:
https://doaj.org/article/2a154a8a1e144ba9b91b347f8b742753
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 104-108 (2024)
The aim of the study – to evaluate the effectiveness of the drug Alflutop (bioactive concentrate of small marine fish), as well as its effect on microcirculation parameters in patients with osteoarthritis (OA) of small joints of the hands.Patients
Externí odkaz:
https://doaj.org/article/1a8d71f6d37c4759bf385fb4750a69b1
Autor:
E. L. Nasonov, V. I. Mazurov, A. M. Lila, T. V. Dubinina, I. Z. Gaydukova, S. A. Lapshina, A. A. Klimenko, D. V. Somov, S. A. Lukianov, D. M. Chudakov, I. V. Zvyagin, O. V. Britanova, M. A. Korolev, D. I. Abdulganieva, D. G. Krechikova, A. A. Kastanayan, L. V. Eliseeva, R. R. Samigullina, T. V. Povarova, O. V. Antipova, S. A. Smakotina, V. N. Soboleva, O. B. Nesmeyanova, T. V. Plaksina, N. F. Soroka, I. B. Vinogradova, A. P. Rebrov, T. V. Kropotina, A. L. Maslyanskiy, A. V. Zinkina-Orikhan, Yu. N. Lin’kova, P. S. Pukhtinskaia, M. A. Morozova, G. A. Vinderskaya
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 65-80 (2024)
The aim – to evaluate the clinical effectiveness, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of seniprutug (BCD-180) in patients with radiographic active axial spondyloarthritis (r-axSpA, or ankylosing spondylitis).Subjects and
Externí odkaz:
https://doaj.org/article/38cd433e63d04c6c9e4e85e988370a30
Autor:
V. I. Mazurov, Sh. F. Erdes, I. Z. Gaydukova, T. V. Dubinina, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, E. P. Ilivanova, A. V. Strelkova, V. V. Tyrenko, E. A. Mikhailova, A. V. Eremeeva
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 35-46 (2024)
The article presents the results of the three-year use of netakimab (NTK) in patients with ankylosing spondylitis (AS) as part of the phase III BCD-085-5/ASTERA study.Objective: to evaluate the long-term efficacy and safety of NTK over a three-year p
Externí odkaz:
https://doaj.org/article/35b1cb81150247aab4f58712cc2503b9
Autor:
Sh. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Yu. Davidian, O. E. Epifanova, N. A. Kiryukhina, L. V. Masneva, I. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Polyatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, J. V. Usacheva, A. L. Chudinov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 700-710 (2024)
Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article presents results of an observational study of netakimab using in routine clinical practice.Methods
Externí odkaz:
https://doaj.org/article/7e5bc44473f34733b5ff6008d493e861
Autor:
T. V. Dubinina, A. B. Demina, E. M. Agafonova, Sh. F. Erdes, V. I. Mazurov, I. Z. Gaydukova, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, V. V. Tyrenko, E. P. Ilivanova, A. V. Strelkova
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 52-58 (2023)
The article contains the data obtained during the 156-week follow-up of patients with ankylosing spondylitis (AS) in the ASTERA phase III study.Objective: to evaluate the effect impact of netakimab (NTK) on quality of life (QoL), back pain and work c
Externí odkaz:
https://doaj.org/article/21939fb7c39048f99cdce239380dea45
Autor:
T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Y. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. A. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 22-30 (2023)
Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease of the joints, spine and entheses from the group of spondyloarthritis, which is usually observed in patients with psoriasis. In recent years, the axial form of PsA (axPsA) has been act
Externí odkaz:
https://doaj.org/article/2ce507c9aff047a4aa939b461df954ab